Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.82 |
| ▸ | MAPT | P10636 | 3/20 | 0.82 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.82 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.82 |
| ▸ | NR3C1 | P04150 | 7/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.68 |
| ▸ | PGR | P06401 | 4/20 | 0.68 |
| ▸ | USP2 | O75604 | 3/20 | 0.68 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.68 |
| ▸ | MLNR | O43193 | 1/20 | 0.68 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.68 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.68 |
| ▸ | PPARG | P37231 | 1/20 | 0.68 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.68 |
| ▸ | MMP1 | P03956 | 3/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.56 |
| ▸ | DRD2 | P14416 | 1/20 | 0.56 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28099304 | 0.92 | LMNA (0.88) | LMNAMAPTSMN1; SMN2NPSR1NR3C1 | |
| SCHEMBL568167 | 0.92 | LMNA (0.88) | LMNAMAPTSMN1; SMN2NPSR1NR3C1 | |
| SCHEMBL5311083 | 0.91 | LMNA (0.79) | LMNAMAPTSMN1; SMN2NPSR1NR3C1 | |
| Clobetasone Butyrate SCHEMBL36599 | 0.90 | LMNA (1.00) | LMNAMAPTSMN1; SMN2NPSR1NR3C1 | |
| Clobetasone Butyrate SCHEMBL11750078 | 0.90 | LMNA (1.00) | LMNAMAPTSMN1; SMN2NPSR1NR3C1 | |
| Clobetasone Butyrate SCHEMBL448850 | 0.90 | LMNA (1.00) | LMNAMAPTSMN1; SMN2NPSR1NR3C1 | |
| Clobetasone Butyrate SCHEMBL29572705 | 0.90 | LMNA (1.00) | LMNAMAPTSMN1; SMN2NPSR1NR3C1 | |
| Clobetasone Butyrate SCHEMBL11124627 | 0.90 | LMNA (1.00) | LMNAMAPTSMN1; SMN2NPSR1NR3C1 | |
| Clobetasone Butyrate SCHEMBL29410388 | 0.90 | LMNA (1.00) | LMNAMAPTSMN1; SMN2NPSR1NR3C1 | |
| Clobetasone Butyrate SCHEMBL14339619 | 0.90 | LMNA (1.00) | LMNAMAPTSMN1; SMN2NPSR1NR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106170285-A | Comprise the pharmaceutical composition of antifungal and steroid | 日本农药株式会社 | 2016-11-30 | — | — | CN | claimed |
| EP-1312356-B1 | AQUEOUS SUSPENSION PREPARATIONS | SENJU PHARMA CO (JP) | 2012-10-17 | — | — | EP | claimed |
| US-20030195179-A1 | Aqueous suspension preparations | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2003-10-16 | — | — | US | claimed |
| EP-1312356-A1 | AQUEOUS SUSPENSION PREPARATIONS | Senju Pharmaceutical Co., Ltd. (JP) | 2003-05-21 | — | — | EP | claimed |
| US-20230041642-A1 | Aggregation Inhibitory Agent and Medical Composition and Medical Device Including Same | NIPRO CORPORATION (JP) | 2023-02-09 | — | — | US | disclosed |
| EP-4079325-A1 | AGGREGATION INHIBITORY AGENT AND MEDICAL COMPOSITION AND MEDICAL DEVICE INCLUDING SAME | Nipro Corporation (JP) | 2022-10-26 | — | — | EP | disclosed |
| CN-114848506-A | Multifunctional personalized patch with therapeutic properties | 强生消费者公司 | 2022-08-05 | — | — | CN | disclosed |
| CN-110799156-B | Multifunctional personalized patch with therapeutic properties | 强生消费者公司 | 2022-05-24 | — | — | CN | disclosed |
| CN-113382730-A | Selective glucocorticoid receptor modifiers for treatment of impaired skin wound healing | 阿克里斯生物医药有限公司 | 2021-09-10 | — | — | CN | disclosed |
| EP-2484383-B1 | METHOD FOR IMPROVING THE AQUEOUS SOLUBILITY OF POORLY-SOLUBLE SUBSTANCES | SANGI KK (JP) | 2021-04-28 | — | — | EP | disclosed |
| CN-112312898-A | Three-dimensional microfluidic device for delivery of active substances | 强生消费者公司 | 2021-02-02 | — | — | CN | disclosed |
| CN-112312892-A | Three-dimensional microfluidic device for delivery of active substances | 强生消费者公司 | 2021-02-02 | — | — | CN | disclosed |
| EP-2821084-A1 | METHOD FOR IMPROVING WATER SOLUBILITY OF SLIGHTLY SOLUBLE SUBSTANCE | Kabushiki Kaisha Sangi (JP) | 2015-01-07 | — | — | EP | disclosed |
| US-8658703-B2 | Aqueous suspension preparations | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2014-02-25 | — | — | US | disclosed |
| US-20120264608-A1 | Method for Improving the Aqueous Solubility of Poorly-Soluble Substances | KABUSHIKI KAISHA SANGI (JP) | 2012-10-18 | — | — | US | disclosed |
| EP-1312356-B1 | AQUEOUS SUSPENSION PREPARATIONS | SENJU PHARMA CO (JP) | 2012-10-17 | — | — | EP | disclosed |
| EP-2484383-A1 | METHOD FOR IMPROVING THE AQUEOUS SOLUBILITY OF POORLY-SOLUBLE SUBSTANCES | KABUSHIKI KAISHA SANGI (JP) | 2012-08-08 | — | — | EP | disclosed |
| US-20090253807-A1 | AQUEOUS SUSPENSION PREPARATIONS | SENJU PHARMACEUTICAL CO. LTD. (JP) | 2009-10-08 | — | — | US | disclosed |
| US-20030195179-A1 | Aqueous suspension preparations | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2003-10-16 | — | — | US | disclosed |
| EP-1312356-A1 | AQUEOUS SUSPENSION PREPARATIONS | Senju Pharmaceutical Co., Ltd. (JP) | 2003-05-21 | — | — | EP | disclosed |